✦ LIBER ✦

Combined modality therapy in stage III and stage IIIE diffuse large cell lymphomas

✍ Scribed by William Velasquez; Lillian M. Fuller; Kyoung K. Oh; Fredrick B. Hagemeister; Jane A. Sullivan; John T. Manning; C. C. Shullenberger

Publisher: John Wiley and Sons
Year: 1984
Tongue: English
Weight: 483 KB
Volume: 53
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19840401)53:7<1478::aid-cncr2820530709>3.0.co;2-t

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

VP-16-213 in the treatment of stage III

VP-16-213 in the treatment of stage III and IV diffuse large cell lymphoma

✍ Peter Jacobs; Helen S. King; David M. Dent; Malcolm Hayes 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 868 KB

The value of combined-modality therapy i

The value of combined-modality therapy in elderly patients with stage III nonsmall cell lung cancer

✍ Steven E. Schild; Sumithra J. Mandrekar; Aminah Jatoi; William L. McGinnis; Phil 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB 👁 2 views

## Abstract ## BACKGROUND. The objective of this study was to assess the value of combined‐modality therapy in elderly patients by comparing the differences in outcome between patients who received radiotherapy (RT) alone and patients who received RT plus chemotherapy for stage III nonsmall cell l

A 10-year experience with combined modal

A 10-year experience with combined modality therapy for stage III small cell lung carcinoma

✍ Renee H. Jacobs; Alice Greenburg; Jacob D. Bitran; Philip C. Hoffman; Kathy S. A 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 693 KB

During the past 10 years, 240 patients with Stage I11 small cell lung carcinoma (SCLC) were treated with one of five chemotherapy programs plus thoracic irradiation. In addition, prophylactic cranial irradiation was administered concurrently with thoracic irradiation to 194 patients receiving CAML-H

Chemotherapy as definitive treatment of

Chemotherapy as definitive treatment of stage I-II large cell and diffuse mixed lymphomas

✍ Fernando Cabanillas 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 387 KB

Combination chemotherapy with adriamycin-containing regimens is effective in the management of advanced lymphomas. In view of this, we treated 43 patients with clinical stage 1-11 large cell or diffuse mixed lymphoma with chemotherapy. Routine staging laparotomies were not done and radiotherapy was

Results of combined-modality therapy for

Results of combined-modality therapy for limited-stage small cell lung carcinoma in the elderly

✍ Steven E. Schild; Philip J. Stella; Burke J. Brooks; Sumithra Mandrekar; James A 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

## Abstract ## BACKGROUND A Phase III trial was conducted by the North Central Cancer Treatment Group to determine whether chemotherapy (etoposide and cisplatin) plus either twice‐daily radiotherapy (BIDRT) or once‐daily radiotherapy (QDRT) resulted in a better outcome for patients with limited‐st

Combined modality therapy for stage IIIM

Combined modality therapy for stage IIIMO non-small cell lung cancer. A five-year experience

✍ Patricia J. Madej; Jacob D. Bitran; Harvey M. Golomb; Philip G. Hoffman Jr; Thom 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 720 KB

Between 1975 and 1980, 101 patients with inoperable Stage IIIMO non-small cell lung carcinoma were entered into combined radiotherapy and chemotherapy trials at Michael Reese Hospital and University of Chicago Hospital. Sixty-four percent of the patients responded. Median survival for all patients w